NCT06818370

Brief Summary

İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
86

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 5, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2026

Completed
Last Updated

February 12, 2025

Status Verified

February 1, 2025

Enrollment Period

11 months

First QC Date

February 5, 2025

Last Update Submit

February 8, 2025

Conditions

Keywords

AlopeciaBreast CancerCoconut Oil

Outcome Measures

Primary Outcomes (1)

  • National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia

    Grade 1; Hair loss of \<50% of normal for that individual that is not obvious from a distance but only on close inspection; a different hair style may be required to cover the hair loss but it does not require a wig or hair piece to camouflage Grade 2; Hair loss of \>=50% normal for that individual that is readily apparent to others; a wig or hair piece is necessary if the patient desires to completely camouflage the hair loss; associated with psychosocial impact

    1-12 WEEK

Study Arms (2)

Experimental group

EXPERIMENTAL

At the beginning of the study,patients will be asked to fill out an individual information form containing demographic information and disease process before the first chemotherapy application.The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.

Other: Coconut Oil

Control Group

NO INTERVENTION

At the beginning of the study,patients will be asked to fill out an individual information form containing demographic information and disease process before the first chemotherapy application. Patients in the control group will be asked not to apply anything to their hair. In each subsequent week, the presence of hair loss of the patients will be evaluated with the alopecia evaluation scale.

Interventions

The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.

Experimental group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • To have been diagnosed with breast cancer.
  • The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol.
  • Volunteer to participate in the study.
  • Be 18 years of age or older.
  • Being a woman.

You may not qualify if:

  • Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases).
  • Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer.
  • Not volunteering to participate in the study.
  • Having previously experienced any disease/skin problem that causes hair loss.
  • Having received chemotherapy before.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsAlopecia

Interventions

Coconut Oil

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesHypotrichosisHair DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Dietary FatsFatsLipidsPlant OilsOils

Central Study Contacts

İsmail Dakdevir, Nurse

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients with breast cancer in the experimental and control groups will be masked.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: It will be conducted in a randomized controlled experimental design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

February 5, 2025

First Posted

February 10, 2025

Study Start

February 3, 2025

Primary Completion

December 31, 2025

Study Completion

January 31, 2026

Last Updated

February 12, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations